• Combines lignocaine with adrenaline in a professional local anaesthetic formulation.
• Adrenaline provides local vasoconstrictor action that can help prolong the anaesthetic effect.
• Supplied in 30 ml vials for professional clinical use.
• Intended for administration only by trained healthcare professionals.
• Pack of 24 vials supports routine clinic procurement.

Indoco Warren Lignox Lignocaine 2% A is a prescription local anaesthetic injection used in professional clinical settings. The formulation combines lignocaine hydrochloride with adrenaline. Indoco lists the 30 ml vial under its Warren NxGen dental portfolio, and the pack supplied here contains 24 vials.

Each millilitre contains lignocaine hydrochloride 24.64 mg and adrenaline 0.0125 mg. The adrenaline component provides local vasoconstrictor action, while lignocaine provides the local anaesthetic effect. The product should be used only by qualified healthcare professionals and in accordance with the current prescribing information, patient assessment and institutional protocols.

For procurement, verify the received batch, expiry and storage instructions printed on the pack before use.

• Dosage form: Sterile solution for injection
• Pack size: 24 × 30 ml vials
• Active composition per ml: Lignocaine Hydrochloride 24.64 mg + Adrenaline 0.0125 mg
• Brand: Lignox 2% A
• Therapeutic role: Local anaesthesia
• Prescription status: Prescription medicine
• Country of origin: India

1 Pack Contains:
• 24 × 30 ml vials

1. This prescription injection must be administered only by a qualified healthcare professional.
2. Verify the product label, batch number, expiry date and solution condition before use.
3. Use the dose, route and technique specified by the prescriber and the approved product information.
4. Do not self-administer this medicine.
5. Follow applicable infection-control, storage and medical-waste disposal requirements.

Manufactured by: Kilitch Drugs India Ltd., India

Not Applicable